Back to search
FDAFDA · Food and drugs·Recall number D-1526-2019

Gericare Geri-Tussin DM, 16 FL OZ (473 mL), Geri-care Phamaceuticals Corp. 1650 63rd Street Brooklyn, NY, NDC 57896-660-16

Published July 31, 2019 · Recall initiated: May 31, 2019

Summary

FDA records drug Class II recall D-1526-2019, published July 31, 2019 and initiated May 31, 2019. Recalling firm: Geritrex, LLC; Status: Terminated; Reported quantity: 6213 bottles; Lot: Lot #: 70602, Exp 6/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: Products may have microbial contamination.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Geritrex, LLC
Distributor
U.S.A. Nationwide
Lot
Lot #: 70602, Exp 6/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gericare Geri-Tussin DM, 16 FL OZ (473 mL), Geri-care Phamaceuticals Corp. 1650 63rd Street Brooklyn, NY, NDC 57896-660-16 recalled?

Yes. FDA published recall D-1526-2019 on July 31, 2019. Reported hazard: cGMP Deviations: Products may have microbial contamination.

What should I do if I have this product?

Voluntary: Firm initiated · Letter